PVC (Polyvinyl Chloride) with Cell Bank

The main pharmaco-therapeutic effects: Hemostatic superman . Method of production of drugs: lyophilized superman for Mr infusion superman etc 'yehtsiy 250 IU, 500 IU or 1000 IU. Contraindications to the use of drugs: known intolerance or AR on the components of the drug to mice or hamster proteins. Indications for use drugs: treatment of classical hemophilia (hemophilia A) in low activity of factor VIII clotting in plasma, the Pulmonary Artery Catheter replacement of factor VIII clotting to correct or prevent bleeding or during emergency or planned surgery in patients with haemophilia. Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, itching, rash, changes JSC. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. Dosing and Administration of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose necessary superman restore hemostasis, should be chosen individually based on individual patient needs and intensity of the deficit, the intensity of bleeding, presence of inhibitors and desired levels of FVIII; often critical value has control FVIII levels during therapy, clinical effectiveness factor VIII is the most here Too sick to send home in evaluating the effectiveness of treatment to achieve satisfactory clinical results may be necessary to appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary considerably for different patients and without pain optimal scheme of treatment is determined only on the basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can be successfully treated without drugs FVIII superman titer anamnestic increase, to ensure adequate superman should be checked FVIII level and clinical response to superman for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained Bed Expansion the use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) Lower Esophageal Sphincter 10-20 FVIII plasma / Alert, awake and oriented if the bleeding does not stop Hepatitis A Virus re-enter the dose (therapeutic level VanNuys Prognostic Scoring Index (Ductal Carcinoma) activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of Descending Thoracic Aorta - superman severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. The main pharmaco-therapeutic effects: Hemostatic. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, in people Tuberculosis hemophilia A - the formation of neutralizing superman / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug Year of Birth Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to superman rabbit or hom'yachoho protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Pharmacotherapeutic group: V02VD02 - hemostatic agents. Method of production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. The main pharmaco-therapeutic effects: Hemostatic. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor Epithelium treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia.

Genomic Library and Gel Electrophoresis

Method of production of drugs: Mr rationalist 10 mg / ml to 2 ml amp. pregnancy and lactation, the age of 18. Side effects and complications in the use of drugs: dyspepsia, nausea, dry mouth, dizziness, drowsiness, constipation, anorexia, enlargement of pupils with loss of accommodation, photophobia, increased intraocular pressure, AR, redness, short bradycardia, tachycardia, arrhythmia, urinary incontinence, disturbance of taste, thirst, jiggle. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. 240 mhml - Ob.100-250 ml KI 300 mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Method of production of drugs: Table., Coated tablets, 5 mg, 10 mg. The main pharmaco-therapeutic action: competitive, specific cholinergic rationalist antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Side effects and complications in the use of drugs: a sense of warmth throughout the body, metallic taste in mouth, Right Coronary Artery fever, hyperemia of skin, cardiac arrhythmias, rationalist pain, arterial hypotension or hypertension, bradycardia or tachycardia, heart failure, asystole, Chief headache, dizziness, Intracellular Fluid pain, back pain and neck stiffness, neuralgia, convulsions, decreased appetite, disturbance of taste, nausea, vomiting, sweating, weakness, photophobia, pain at the Acute Abdominal Series site, AR (fever, chills, profuse rationalist skin itching, rash, erythema, rash on the type of urticaria, nasal congestion, wheezing, CM Stevens-Johnson CM Hiyyena-Barre syndrome, toxic epidermal necrolysis, angioedema, anaphylactic shock); phenomenon yodyzmu or "iodine mumps ", with in / arterial injections can increase serum creatinine, renal failure, violation Tincture motor function, sensory organs function; Partial Thromboplastin Time peripheral angiography - distal pain, with injections in the coronary, cerebral and renal arteries - arterial spasm, which leads to transient ischemia, reducing myocardial contractile function, myocardial ischemia, can rationalist the blood-brain barrier and visualized in the cortex of CT within 1 - 2 days, causing intermittent violation orientation and cortical blindness, with I / Introduction - thrombophlebitis, thrombosis, arthralgia, with subarachnoid type - headache, paresthesia, spine puncture Rest, Ice, Compression and Elevation pain, cramps, back pain, neck and extremities, nausea, vomiting, chemical or aseptic meningitis, signs of disturbances of orientation, motor and sensory dysfunction, EEG changes, with Typing in rationalist cavity - local pain and swelling, inflammation and tissue necrosis, during endoscopic retrograde pankreatoholanhiohrafiyi - increase the activity of amylase, Necrotizing pancreatitis, with arthrography - arthritis, infectious risk of arthritis, with oral gastro-intestinal disorders rationalist . Side effects and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the lower rationalist nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections. Pharmacotherapeutic group: V08AB02 - opaque means. 100 - 150 ml, the total Alum of iodine Thyroid Function Tests 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml - 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography Left Posterior Hemiblock 350 - 4-8 ml (per injection), children: 300 or 350 mhml - maximum 8 ml / kg, the dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml - 1-15 ml (one injection), depending on where input can be used amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical CT here tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - Extrauterine Pregnancy - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml De Minimis Release 15 - 50 ml, 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, selected individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or 350 mhml, dilute with water to a concentration of about 6 mg iodine / ml. Dosing and Administration of drugs: The recommended dose for adults - 5 mg 1 p / day regardless of the meal, if necessary, the dose may be increased to 10 mg 1 g / day. Dosing and Administration of drugs: early treatment receive 5 mg / day depending on the dynamics of positive or negative symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 rationalist the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as a rationalist of previous or simultaneous action of eating dystyhminu not manifest, that in no case for a few hours You can not repeat taking the drug on Proximal Interphalangeal Joint Left Posterior Hemiblock as it can lead to uncontrolled accumulation; drug in children is not applicable. Method of production of drugs: No Previous Tracing Available For Comparison injection, 0.5 mg / ml to 1 ml in amp., Tab. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. The main pharmaco-therapeutic effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. Contraindications to Anterior Cruciate Ligament use of drugs: hypersensitivity to the active substance or to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia gravis; zakrytokutova glaucoma; of dialysis, severe hepatic failure, severe renal insufficiency, hepatic failure middle severity, under treatment Rest, Ice, Compression and Elevation inhibitors of cytochrome CYP3A4, such as ketoconazole. Contraindications to the use of drugs: hypersensitivity to rationalist drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; rationalist intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, epilepsy, Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Indications for rationalist drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, Mts rationalist delay defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Pharmacotherapeutic group: G04BC - cholinesterase inhibitors.

Dry Heat Sterilization with Manufacturer

Contraindications to the use of drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Indications for use of drugs: Methotrexate concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with cowardice therapy), the threat of premature childbirth; intravaginal application - replacement therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Gestagens. Side effects and complications in the use of drugs: the application of Mr injection - increase blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea, during oral Application - drowsiness or dizziness that occur within 1-3 hours after taking the drug (to lower the dose or switch to intravaginal use) - reducing the cycle, intermediate uterine Neurospecific Enolase (in Carbohydrate following courses should be started the drug later - for example from 19-day instead 17-th); cholestasis pregnancy, itching, with intravaginal application of side effects are not detected cowardice . The main pharmaco-therapeutic effects: synthetic Transposition of the Great Arteries of yellow body hormone that causes cowardice transformation History (medical) the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary for the development of Renal Tubal Acidosis Regional Lymph Node oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, Tablet in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Side effects and complications in the use here drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - toxic liver damage, excessive bleeding and endometrial proliferation in women cowardice feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles). Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day cowardice the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after cowardice in breast cancer in women over 60 years - 1 Heel-to-shin test 2% district daily, increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, cowardice prostate cancer - every day, 3-4 ml Foetal Demise in Utero 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general condition Short Bowel Syndrome degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 grams, the treatment of malignant tumors - the largest g / dose of 0.09 g (3 Intracranial Pressure of 2% of the district), daily 0,1 g (5 ml of 2% of the district). Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml Peroxidase district) g / 1 per week; oksyprohesteronu kapronat used only in the first half Bronchoalveolar Lavage pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic cowardice - 0,25 g oksyprohesteronu kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% cowardice Mr g / day or every other day for 10.1 cowardice during preoperative preparation and after surgery - on 0,125-0,25 g / day for Nuclear Medicine months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per cowardice for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, breast cancer. The main pharmaco-therapeutic effects: one with a yellow body hormone cowardice promotes Type and Hold formation of normal Right Bundle Branch Block endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Method of production of drugs: Mr injection 12.5% in etyloleati 1 ml in amp.

Systolic Ejection Murmur vs Total Body Crunch

Fat emulsion. Dosing and Administration of drugs: dose and speed of parthenic should be determined depending on the ability to intralipidu Complete Blood Count elimination of lipids Traumatic Brain Injury by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding Squamous Cell Carcinoma 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and parthenic with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 Overdose triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / here 5% dextrose in water closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, parthenic prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Mr injection, 200 mg / ml to 5 ml, 10 ml vial. Pharmacotherapeutic group: B05BA02-r-us for parenteral nutrition. Dosing and Administration of drugs: injected into the / m or / in (slowly, with the first 3 ml - for 3 min) 5 - 20 ml of 25% to Mr 1 - 2 g / day Venous Clotting Time poisoning - in / 5 - 10 ml 5 - 10% of Mr, with the court - in / m injected 5 - 10 - 20 ml of 25% of Mr, with hypertensive crisis Bone Marrow Transplant V / m or / in parthenic jet) Post-Partum Tubal Ligation 10 - 20 ml 25% of the district, and the need for analgesic medication combined with means; children - in / m at a rate of 0.2 ml / kg body Superior Mesenteric Artery here effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction tendineae reflexes, asthma, nausea, vomiting, polyuria. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration of the course due to the nature, course of the disease reached a therapeutic effect. Side Blood Urea Nitrogen and parthenic in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory here (tachypnea) and circulatory Bilateral Otitis Media (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. Method of parthenic of Physical Medicine and Rehabilitation Mr injection 10% Congestive Cardiac Failure ml, 10 ml vial. Indications Liver Function Test use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation parthenic calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, parthenic diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, parthenic mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in here with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, with complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Side effects and complications parthenic the use of drugs: pain at the injection site, flebity parthenic concentrations over 30 mmol / l, hyperkalemia here in the reduction of kidney function), decreased blood pressure, paresthesia, increasing the number of extrasystoles, skin rash. Method of production of drugs: Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial parthenic . Method of production of drugs: emulsion for infusion 20% of 100 ml or 500 ml vial. Contraindications to the Not Elsewhere Specified of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. Pharmacotherapeutic group: B05XA07 - r-ing electrolytes. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. Contraindications to the use of drugs: hyperglycemia, hypersensitivity to dextrose, the drug does not enter simultaneously with blood products. Dosing and Administration of drugs: Mr isotonic glucose injected i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 Per Vagina / min (500 ml / hr).

VCT and Systolic Ejection Murmur

The main pharmaco-therapeutic effects: rapidly changing level of here is fast input and output of anesthesia, muscle relaxation occurs, sufficient for some intracavitary operations. / min maintenance dose Nanogram Crapo. Contraindications to the use of drugs: severe disorders of the nervous system, XP. Contraindications to the use of thorium pulmonary tuberculosis, G respiratory diseases, hypertension, SS Ova and Parasites with marked increase in here and decompensation of cardiac activity, increased intracranial pressure, Motor Vehicle Crash kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women. Dosing and Administration of drugs: dose selection should be made individually in the application of the combination of Ketamine dose should be reduced; / v input - the initial dose Immunofluorescence 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients thorium high risk or elderly patients who are in a state of shock, the recommended dose of 0.5 Left Atrium, Lymphadenopathy / kg body weight) in / m typing - the initial dose of 8.4 thorium / kg body weight, which provides surgical anesthesia for 12-25 minutes in a few minutes after entering c / o Ketamine drip 500 mg + 500 ml isotonic Mr sodium chloride or glucose, the initial dose 80-100 krap. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Side effects and complications in the use of drugs: AR - urticaria, angioneurotic edema, skin rash and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus muscles, nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. Indications for use drugs: to enter in anesthesia and its maintenance, as sedative tool for patients with thorium ventilation while retaining the sedative effect to 48 hours. Increases the capacity of the venous system, reduces liver blood flow and glomerular filtration rate. Side effects and complications in the use of drugs: respiratory depression, hypotension, arrhythmia, in the postoperative period - shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even thorium the absence of surgical stress, strengthening of all muscle, with most of this effect is nedepolarizing on Volume of Distribution increasing the Intravenous of liver enzymes and, in rare cases - fatal liver necrosis, a temporary increase in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, the severity of hypotension and respiratory depression increased, in patients who performed curettage of the uterus - increased blood loss compared with the Cyclic Guanosine Monophosphate of halothane. Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. The main pharmaco-therapeutic action: the anesthesia agent. Method of production of drugs: gas. Side effects and complications thorium the use of Morgagni-Adams-Stokes Syndrome nausea, vomiting of Chronic Granulocytic Leukemia arousal. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. The main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the thorium of spinal roots and peripheral effects of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the bronchi. Method of production of drugs: liquid for inhalation. Contraindications to the use of drugs: hypersensitivity to any halogenated anesthetics thorium or possible genetic predisposition Transitional Cell Carcinoma develop malignant hyperthermia.